← EU Feed

$26.05 Bn Oral Transmucosal Drugs Market Share Analysis, Industry Trends & Statistics, Growth Forecasts, 2031

AI Briefing

  • Expanding use in opioid dependence, seizures, and pain management drives growth
  • Needle-free dosing preference and film technology advancements fuel industry
  • Regulatory support and evolving drug pipelines targeting CNS disorders encourage growth
Advertisement
Read Original Article